BioCentury
ARTICLE | Clinical News

Architect HBsAg Qualitative II assay regulatory update

November 14, 2011 8:00 AM UTC

Abbott received CE Mark approval for its Architect HBsAg Qualitative II assay to aid in the diagnosis of HBV infection and for screening donated blood and plasma. The chemiluminescent microparticle im...